It was 150 years ago, on September 23, 1872 that a well-known pioneer of the Hungarian pharmaceutical industry, Gedeon Richter was born. Today, the Budapest-based company bearing his name is present in 50 countries of the world. In 1901, Gedeon Richter bought the Sas Pharmaceutical Factory in Budapest, where he set up a laboratory for […]

Hungarian pharmaceutical company Gedeon Richter Plc. said that it launched a biosimilar teriparatide drug called Terrosa® in Europe. The product is approved in adults for the same indications as Eli Lilly’s Forsteo® and is used for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. Terrosa is also used […]

Hungarian pharma firm Gedeon Richter has signed an exclusive license agreement with Hikma Pharmaceuticals Plc. to sell Richter's anti-psychotic drug ‘cariprazine’ in some Middle Eastern and North African (MENA) markets. Under the terms of the agreement, Richter will be responsible for product supply and Hikma will proceed with the registration and commercialization of the product […]